Search

Membership is a widely accepted mark of excellence in science and considered one of the highest honors a scientist can receive.

… Tuesday, April 28, 2020 Two Sloan Kettering Institute (SKI) researchers have been elected to the National Academy of Sciences (NAS). Scott Keeney, PhD , a molecular biologist, and Christopher Lima, PhD , a structural biologist, join more than a dozen Memorial Sloan Kettering investigators who are already

Visible Ink at Memorial Sloan Kettering Cancer Center (MSK) is the leading — and largest — writing program of its kind. Writing promotes creativity, reduces stress, and empowers people with cancer to give voice to their stories.

… Friday, April 6, 2018 Visible Ink at Memorial Sloan Kettering Cancer Center (MSK) is the leading — and largest — writing program of its kind. Writing promotes creativity, reduces stress, and empowers people with cancer to give voice to their stories. On Monday, April 16 at 6:30 p.m. , the Kaye Playhouse

Dr. Perales was formally sworn in during the 2023 Tandem Transplantation and Cellular Therapy Meetings of ASTCT and the Center for International Blood and Marrow Transplant Research (CIBMTR) on February 18.

… Monday, February 20, 2023 Miguel-Angel Perales, MD , of Memorial Sloan Kettering Cancer Center (MSK), has been named President of The American Society for Transplantation and Cellular Therapy (ASTCT) for 2023-2024. Dr. Perales was formally sworn in during the 2023 Tandem Transplantation and Cellular

Memorial Sloan Kettering Cancer Center (MSK) today celebrated the opening of a $1.5 billion state-of-the-art cancer treatment facility with government officials, members of the Boards of Overseers and Managers, and staff. Opening for patient care next month, the 750,000-square-foot building is the institution’s — and the city’s — largest freestanding cancer care facility. The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center is a healing community dedicated to patient-centered care, made possible by a landmark donation and a pioneering vision that signifies a new era of cancer care.

… Tuesday, December 10, 2019 Memorial Sloan Kettering Cancer Center (MSK) today celebrated the opening of a $1.5 billion state-of-the-art cancer treatment facility with government officials, members of the Boards of Overseers and Managers, and staff. Opening for patient care next month, the 750,000-square-foot

MSK investigators have used a lab tool originally developed to study fly nerve cells to uncover new findings about acute myeloid leukemia.

… Monday, April 27, 2020 Summary MSK investigators have used a lab tool originally developed to study fly nerve cells to study RNA-binding proteins in blood cells from mammals. The technique has allowed them to uncover new clues about acute myeloid leukemia. If you think of cells as factories for making

Read the inspiring story of two MSK employees, Jennifer Brosnan and Santosha Vardhana, and why they lead Cycle For Survival teams to raise money to support research into rare cancers.

… Monday, June 10, 2024 Even when they’re off the clock, the people of MSK devote themselves to raising money for cancer research through events like Cycle for Survival® , MSK’s biggest fundraising event of the year, focused on conquering rare cancers. These are just two of the people who epitomize the

New MSK research sheds new light on how the gut protects itself by sensing gut bacteria; finds a subtype of glioma-associated macrophages that appear to play a pivotal role in progression; and demonstrates that reduced surgery is an option for some thyroid cancer patients.

… Tuesday, January 20, 2026   New research from Memorial Sloan Kettering Cancer Center (MSK) sheds new light on how the gut protects itself by sensing gut bacteria; finds a subtype of glioma-associated macrophages that appear to play a pivotal role in progression; and demonstrates that reduced surgery

Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic.

… Monday, December 22, 2008 Researchers have developed a new generation of microscopic particles for molecular imaging, constituting one of the first promising nanoparticle platforms that may be readily adapted for tumor targeting and treatment in the clinic. Highly sensitive and specific probes and molecular

MSK physicians and researchers discussed the latest trends in breast cancer research at the annual meeting held in San Antonio.

… Thursday, December 9, 2021 This week at the annual San Antonio Breast Cancer Symposium (SABCS), MSK researchers discussed some of the latest advances in breast cancer treatment and led educational sessions about improving ways to treat and manage the disease. Here are some of the noteworthy presentations

On Tuesday, December 2, MSK hosted "Demo Day 2025," a strong follow-up to the institution’s November 2025 “Innovation with Lasting Impact Summit” on entrepreneurship and innovation.

… Monday, January 12, 2026 On Tuesday, December 2, MSK hosted “ Demo Day 2025 ,” a strong follow-up to the institution’s November 2025 “ Innovation with Lasting Impact Summit ” on entrepreneurship and innovation. Fifteen cutting-edge companies selected to work with MSK’s laboratory, clinical, and digital